Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells
about
MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological diseaseTranscription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivoMEF2 transcription factors: developmental regulators and emerging cancer genesMEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat modelUtilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injuryAscl1/Mash1 is a novel target of Gli2 during Gli2-induced neurogenesis in P19 EC cells.An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.Ethanol diverts early neuronal differentiation trajectory of embryonic stem cells by disrupting the balance of lineage specifiersManufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapyPotential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells.Inducible knockout of Mef2a, -c, and -d from nestin-expressing stem/progenitor cells and their progeny unexpectedly uncouples neurogenesis and dendritogenesis in vivo.High-frequency hippocampal oscillations activated by optogenetic stimulation of transplanted human ESC-derived neurons.MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways.Stem cell transplantation for neuroprotection in stroke.ATM-dependent phosphorylation of MEF2D promotes neuronal survival after DNA damage.The MEF2 family and the brain: from molecules to memory.Myocyte enhancer factor 2C in hematopoiesis and leukemia.S-Nitrosylation in neurogenesis and neuronal development.Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.The transcriptional response to chronic stress and glucocorticoid receptor blockade in the hippocampal dentate gyrus.mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2.Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency.Optogenetic Stimulation of Neural Grafts Enhances Neurotransmission and Downregulates the Inflammatory Response in Experimental Stroke Model.The MEF2C-Related and 5q14.3q15 Microdeletion Syndrome.Recent Advances in Stem Cell-Based Therapeutics for Stroke.NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism.Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell.miR-124 and miR-9 mediated downregulation of HDAC5 promotes neurite development through activating MEF2C-GPM6A pathway.Neuregulin1β Effects on Brain Tissue via ERK5-Dependent MAPK Pathway in a Rat Model of Cerebral Ischemia-Reperfusion Injury.Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.Functional engraftment of the medial ganglionic eminence cells in experimental stroke model.HDAC4 in ischemic stroke: mechanisms and therapeutic potential
P2860
Q24318325-442D0A00-7BBC-4E32-AFEE-246DF0AC4FEEQ24644531-349BD51E-B0BE-4D77-A93F-6EE09AE3BD9AQ26778515-2347C470-2199-4AFD-A13D-EFF749BA16ACQ27322685-4ED7169A-9AD3-4501-9675-BA9A1C5F799DQ28072473-A3C7A4B9-13EE-4D6B-97F6-5FB5A9EDBDA3Q33895175-3C2A9E86-ECF5-4039-926A-FC2F125994DBQ34107076-165B14B4-EDD7-4708-88EA-D3587288269CQ34749329-92CB729B-D057-4F64-9148-68E41441797AQ35111696-DB6548B7-14E4-418B-B829-1F687F6AA62FQ35299587-A0C5EBB3-AF13-47CF-9342-0A3AC2DEFB46Q36299874-78AA56EF-2658-4A3F-88E3-D93A87AA662CQ36441981-B19DDAF7-F685-4FD4-85DA-A15141DD5955Q37172192-BFA4D1DE-08FA-441C-A40F-80C13F7F98CEQ37238494-56298FFF-CCCC-4C1C-8E52-E93358902E9DQ37663170-3BCDD35D-71C5-43AF-ACF2-75778521C122Q38080479-50CDD00D-3273-4AAD-9E44-E349230E4C4EQ38084093-1DEDEF18-B884-4E9A-B393-D43E1722B390Q38295325-F3EC6E48-B575-49BF-91EC-9722576D922FQ39796090-C4C4169F-CFDB-4532-8949-DC1AE222C5D1Q39801587-8601710D-6E33-4D44-8EED-296AA1BA8212Q39839348-0BA0C3EC-D3E1-4F36-B311-0609DFE660E4Q40110721-3C7A0CA6-7AAA-46CE-95C7-02BECFB6EA0BQ40778030-0C3233A2-5FBB-4F16-8636-AA150132417BQ42183498-D7B8A5B8-BE03-4FF3-901E-0D576F6E496AQ44836823-8606D7E3-6E00-40D9-B152-E68386AB07E1Q46098319-0D83EB05-28C7-4D06-BC2C-5780354823AEQ47405412-F597BC9B-5CCC-468E-BB4B-37A5D0BC530AQ48088459-E69C4CCC-131D-40FC-913B-FC4FF24A96C4Q48278462-95C9059F-0D44-4B0D-B35E-F3F90D70EB1BQ48337519-8A86EEAA-BD61-49A5-AAC4-F4C8D62765DDQ48584774-6D197FED-7867-4739-8953-B3063AC9BA1EQ58747047-9E42BED0-999B-465A-96AD-26902F4BCE0E
P2860
Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells
description
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Juni 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/06/25)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/06/25)
@nl
наукова стаття, опублікована в червні 2008
@uk
مقالة علمية (نشرت في 25-6-2008)
@ar
name
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@ast
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@en
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@nl
type
label
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@ast
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@en
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@nl
prefLabel
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@ast
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@en
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@nl
P2093
P2860
P3181
P1476
Myocyte enhancer factor 2C as ...... in murine embryonic stem cells
@en
P2093
Amanda J. Roberts
Jeffrey H. Lipton
Jiankun Cui
Maria Talantova
Scott R. McKercher
Shu-ichi Okamoto
Stuart A. Lipton
Tina Sallmen
Walid Soussou
P2860
P304
P3181
P356
10.1523/JNEUROSCI.0134-08.2008
P407
P577
2008-06-25T00:00:00Z